Indications |
Intravenous Severe infections Adult: As sodium: 200-300 mg/kg daily in divided doses or 3-4 g every 4 or 6 hr. For life-threatening conditions especially those caused by Pseudomonas or Klebsiella spp: At least 16 mg/day. Usual max dose: 24 g/day. Child: As sodium: 1 mth-12 yr: 100-300 mg/kg daily in 3-4 divided doses. Neonate: <7 days or <2 kg: 150 mg/kg daily in 3 divided doses; >7 days and >2 kg: 300 mg/kg in 3-4 divided doses. IV route is preferred for infants and children. Single doses >500 mg should not be given via IM inj. Renal impairment: Moderate-severe: Dose reduction is necessary. Parenteral Mild or uncomplicated infections Adult: As sodium: 100-125 mg/kg daily. Usual dose: if given via IV inj/infusion, 2 g every 6 or 8 hr or 4 g every 12 hr; if given via IM inj, 2 g every 8 or 12 hr. Child: As sodium: 1 mth-12 yr: 100-300 mg/kg daily in 3-4 divided doses. Neonate: <7 days or <2 kg: 150 mg/kg daily in 3 divided doses; >7 days and >2 kg: 300 mg/kg in 3-4 divided doses. IV route is preferred for infants and children. Single doses >500 mg should not be given via IM inj. Renal impairment: Moderate-severe: Dose reduction is necessary. Parenteral Prophylaxis of infection during surgery Adult: As sodium: 2 g just before the procedure or when the umbilical cord is clamped in caesarean section, followed by at least 2 doses of 2 g at intervals of 4 or 6 hr within 24 hr of procedure. Renal impairment: Moderate-severe: Dose reduction is necessary. Intramuscular Uncomplicated gonorrhoea Adult: As sodium: 2 g as a single dose in combination with 1 g oral dose of probenecid given 30 min before the inj. Renal impairment: Moderate-severe: Dose reduction is necessary. Special Populations: Reduce dose in patients with moderate to severe renal impairment. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Renal impairment; heart failure. Pregnancy. Prolonged treatment may increase risk of superinfection, leukopenia, neutropenia and bleeding manifestations. Increased risk of fever and rash in cystic fibrosis patients. Monitor renal, hepatic and haematological functions during prolonged and high-dose therapy. |
Adverse Reactions |
GI disturbances; hypersensitivity reactions; eosinophilia, hyponatraemia, hypokalaemia. Injection-site related reactions such as pain, erythema and induration. Potentially Fatal: Anaphylactic reactions; prolongation of bleeding time; CNS toxicity. |
Drug Interactions |
Clearance reduced by probenecid. May prolong bleeding time when used with anticoagulants. Increased risk of aminoglycoside-associated nephrotoxicity when used together. Concurrent use may increase risk of methotrexate toxicity due to reduced clearance. Increased neuromuscular block when used with neuromuscular blockers. See Below for More piperacillin Drug Interactions |
Lab Interactions |
Interferes with urinary glucose using copper sulfate and false-positive results in urinary or serum protein, uric acid and urinary test. |
Mechanism of Actions |
Piperacillin inhibit septum and cell wall synthesis and has an antimicrobial activity against a wide range of gm-ve organisms including K. pneumoniae, P. aeruginosa, Enterobacteriaceae and against Garm-positive organisms eg, E. faecalis and B. fragilis. Absorption: Not absorbed when given orally. IM: well absorbed with peak plasma concentrations after 30-50 min. Distribution: Widely distributed into body tissues and fluids, CSF (small amounts except when the meninges are inflamed), bile (high concentrations); crosses the placenta and enters the breast milk. Protein-binding: 20% Excretion: Via the urine by glomerular filtration and tubular secretion (60-80% unchanged), via the bile (20%); may be removed by dialysis. Elimination half-life: 1 hr; 4-6 hr (end-stage renal failure), 3-fold increase (severe renal insufficiency), prolonged in neonates and in renal and hepatic impairment. |
Storage Conditions |
Intramuscular: Store at 20-25 °C. Intravenous: Store at 20-25 °C. Parenteral: Store at 20-25 °C. |
ATC Classification |
J01CA12 - piperacillin ; Belongs to the class of penicillins with extended spectrum. Used in the systemic treatment of infections. |
Storage |
Intramuscular: Store at 20-25 °C. Intravenous: Store at 20-25 °C. Parenteral: Store at 20-25 °C. |
Available As |
|
Piperacillin
Post Review about Piperacillin Click here to cancel reply.
Piperacillin Containing Brands
Piperacillin is used in following diseases
Drug - Drug Interactions of Piperacillin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.